Login
From:
Drug Discovery and Development
(Uncensored)
subscribe
Q&A: AnaptysBio's CMO on rosnilimab's 'compelling' phase 2b RA results - Drug Discovery and Development
https://www.drugdiscoverytrends.com/qa-anaptysbios-cmo-on-rosnilimabs-compelling-phase-2b-ra-results/
links
backlinks
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
Roast topics
Find topics
Find it!
